Alendronate 70 mg Once Weekly and alendronate 10 mg Once Daily preference study in postmenopausal women with osteoporosis.

被引：0
|
作者：
Palmisano, J
Lewiecki, EM
Rosen, C
Bockman, RS
Vanaman, LK
Smith, M
Wang, L
Yates, J
机构：
[1] Merck & Co Inc, W Point, PA USA
[2] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA
[3] Maine Ctr Osteoporosis, Bangor, ME USA
[4] Hosp Special Surg, New York, NY 10021 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [21] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Foldes, J
    Uebelhart, B
    Peverly, C
    Santora, A
    Kaur, A
    Wu, M
    Orloff, J
    BONE, 2001, 28 (05) : S94 - S94
  • [22] Alendronate 70 mg once weekly Vs. placebo: Tolerability study in patients with osteoporosis
    Palmisano, J
    Melton, M
    Greenspan, SL
    Field-Munves, EM
    Tonino, RP
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S27 - S27
  • [23] The effects of once-weekly alendronate 70 mg on bone metabolism of postmenopausal women in Korea.
    Kim, H
    Shon, H
    Choi, J
    Lee, H
    Kim, E
    Park, I
    Park, I
    Kim, B
    Lee, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S394 - S394
  • [24] Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
    Greenspan, SL
    Bone, G
    Schnitzer, TJ
    Watts, NB
    Adami, S
    Foldes, AJ
    Roux, C
    Levine, MA
    Uebelhart, B
    Santora, AC
    Kaur, A
    Peverly, CA
    Orloff, JJ
    Rizzoli, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (11) : 1988 - 1996
  • [25] Once-weekly alendronate: Two year subgroup efficacy analyses in postmenopausal women with osteoporosis.
    Bone, H
    Felsenberg, D
    Greenwald, M
    Schnitzer, T
    Kaur, A
    Cudny, M
    Peverly, C
    Orloff, J
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S526 - S526
  • [26] TREATMENT WITH ONCE-WEEKLY ALENDRONATE 70 MG COMPARED TO ONCE-WEEKLY RISEDRONATE 35 MG IN WOMEN WITH POSTMENOPAUSALE OSTEOPOROSIS: A RANDOMIZED DOUBLE-BLIND STUDY
    Pietschmann, Peter
    JOURNAL FUR MINERALSTOFFWECHSEL, 2005, 12 (01): : 36 - 38
  • [27] Patients with osteoporosis prefer once weekly to once daily dosing with alendronate
    Kendler, D
    Kung, AWC
    El-Hajj Fuleihan, G
    González, JGG
    Gaines, KA
    Verbruggen, N
    Melton, ME
    MATURITAS, 2004, 48 (03) : 243 - 251
  • [28] Safety of once-weekly alendronate 70 mg in periodontal disease
    Van Dyke, T
    Ryder, M
    Cordero, R
    Gallagher, A
    Griffiths, G
    Offenbacher, S
    Cizza, G
    Kimberlin, M
    Lombardi, A
    Meng, L
    Shih, W
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 26 - 26
  • [29] COMPARING DAILY STRONTIUM RANELATE WITH ONCE WEEKLY ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Galesanu, Corina
    Lisnic, Natalia
    Florescu, Alexandru
    Loghin, Andra Iulia
    Aancute, Adrian
    Zaharia, Valentin
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S88 - S88
  • [30] Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis
    T. Schnitzer
    H. G. Bone
    G. Crepaldi
    S. Adami
    M. McClung
    D. Kiel
    D. Felsenberg
    R. R. Recker
    R. P. Tonino
    C. Roux
    A. Pinchera
    A. J. Foldes
    S. L. Greenspan
    M. A. Levine
    R. Emkey
    A. C. Santora
    A. Kaur
    D. E. Thompson
    J. Yates
    J. J. Orloff
    Aging Clinical and Experimental Research, 2000, 12 (1) : 1 - 12
12345